Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management
Early Phase 1
Not yet recruiting
- Conditions
- Chronic PainInterstitial CystitisPelvic Floor; RelaxationPelvic Floor Disorders
- Interventions
- Device: High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical deviceDrug: Botulinum Neurotoxin
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- HillMed Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT05062902
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
News
No news found